BrainSpace announced that the FDA granted 510(k) clearance for its Intellidrop automated brain fluid management system.

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ...

For years, we've thought of autism as lying on a spectrum, but emerging evidence suggests that it comes in several distinct ...

The US government is approving the drug leucovorin to address rising rates of autism, despite limited evidence that it works.

The INSIDE Institute for NeuroAI has demonstrated that non-invasive brain–computer interfaces (BCIs) are no longer confined ...

BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Stikeleather’s passion for the cause grew from a journey that began as a special education teacher in her native Philippines ...

A family case narrative and recent research highlight how EEG-guided rTMS is being studied in autism research. WIMBERLEY, TX, UNITED STATES, December 30, 2025 /EINPresswire.com/ — Brain Treatment USA ...

Galaxy Therapeutics announced it has completed enrollment in the SEAL IT pivotal trial evaluating the company’s saccular ...

A recent study finds that certain psychiatric disorders have considerable genetic overlap. But these genes aren’t the whole ...